Arizona Alzheimer's Disease Research Center (ADRC)
The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United States, and a leading example of statewide collaboration in biomedical research. It capitalizes on Arizona's strengths in brain imaging, genomics, computer science and biomathematics, the basic, cognitive and behavioral neurosciences, clinical, and neuropathological studies of AD, the discovery and evaluation of investigational treatments, and the study of normal cognitive aging.
Conditions:
🦠 Alzheimer Disease
🗓️ Study Start (Actual) 1 October 2021
🗓️ Primary Completion (Estimated) 30 June 2026
✅ Study Completion (Estimated) 30 June 2026
👥 Enrollment (Estimated) 550
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Phoenix, Arizona, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Cognitively normal persons, individuals with mild cognitive impairment or dementia who are at least 40 years of age.
    • * Willing to undergo health and cognitive assessments, and collection and banking of blood with venipuncture for genetic research, biomarker research, and DNA banking.

    Exclusion Criteria:

    • * 1. Participants whose diagnosis is unclear and confounded by multiple possible factors are excluded. Participants with diagnoses of non-AD dementias are not excluded.
    • 2. Participants whose primary diagnosis is cognitive impairment due to a penetrating or single severe closed head injury, multiple sclerosis, brain tumor, metabolic or toxic encephalopathy, post-infectious (e.g., viral encephalitis, bacterial meningitis), paraneoplastic, primary psychiatric illness, or otherwise not deemed relevant to the intent of the Alzheimer Disease Center program are excluded.
    • 3. Procedure specific exclusion criteria also apply but this does not impact the participants ability to be included in the study.
Ages Eligible for Study: 40 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 4 March 2022
  • First Submitted that Met QC Criteria 2 June 2022
  • First Posted 6 June 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 10 June 2024
  • Last Update Posted 11 June 2024
  • Last Verified July 2023